These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 25637287)

  • 1. Invasive meningococcal disease in the 21st century—an update for the clinician.
    Dwilow R; Fanella S
    Curr Neurol Neurosci Rep; 2015 Mar; 15(3):2. PubMed ID: 25637287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of meningococcal infections in the first 2 years of life.
    Woods CR
    Pediatr Ann; 2013 Aug; 42(8):164-71. PubMed ID: 23910030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing and dynamic epidemiology of meningococcal disease.
    Halperin SA; Bettinger JA; Greenwood B; Harrison LH; Jelfs J; Ladhani SN; McIntyre P; Ramsay ME; Sáfadi MA
    Vaccine; 2012 May; 30 Suppl 2():B26-36. PubMed ID: 22178525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vaccination on meningococcal epidemiology.
    Stefanelli P; Rezza G
    Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bexsero® chronicle.
    Vernikos G; Medini D
    Pathog Glob Health; 2014 Oct; 108(7):305-16. PubMed ID: 25417906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological implications of meningococcal disease.
    Meredith ; Galwankar S
    J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004-2020.
    Burton C; Best E; Broom M; Heffernan H; Briggs S; Webb R
    Emerg Infect Dis; 2023 Apr; 29(4):686-695. PubMed ID: 36957984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.
    Dull PM; McIntosh ED
    Vaccine; 2012 May; 30 Suppl 2():B18-25. PubMed ID: 22607895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative.
    Aye AMM; Bai X; Borrow R; Bory S; Carlos J; Caugant DA; Chiou CS; Dai VTT; Dinleyici EC; Ghimire P; Handryastuti S; Heo JY; Jennison A; Kamiya H; Tonnii Sia L; Lucidarme J; Marshall H; Putri ND; Saha S; Shao Z; Sim JHC; Smith V; Taha MK; Van Thanh P; Thisyakorn U; Tshering K; Vázquez J; Veeraraghavan B; Yezli S; Zhu B
    J Infect; 2020 Nov; 81(5):698-711. PubMed ID: 32730999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations for controlling invasive meningococcal disease in high income countries.
    Holst J; Nøkleby H; Bettinger JA
    Vaccine; 2012 May; 30 Suppl 2():B57-62. PubMed ID: 22607900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of meningococcal vaccines and their serological correlates of protection.
    Vipond C; Care R; Feavers IM
    Vaccine; 2012 May; 30 Suppl 2():B10-7. PubMed ID: 22607894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.
    Atkinson B; Gandhi A; Balmer P
    Pharmacotherapy; 2016 Aug; 36(8):880-92. PubMed ID: 27332671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in meningococcal epidemiology and current vaccine recommendations.
    Baltimore RS
    Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine prevention of meningococcal disease, coming soon?
    Morley SL; Pollard AJ
    Vaccine; 2001 Dec; 20(5-6):666-87. PubMed ID: 11738731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for eradication of meningococcal disease.
    Nadel S
    Arch Dis Child; 2012 Nov; 97(11):993-8. PubMed ID: 22984187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.
    Sáfadi MA; McIntosh ED
    Expert Rev Vaccines; 2011 Dec; 10(12):1717-30. PubMed ID: 22085175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.